LSM2 and glioblastoma: Furthermore, elevated expression of IL13RA1 has also been associated with poor prognosis in patients with invasive breast cancer (Park et al., 2017), poor prognosis and drug resistance in glioblastoma multiforme patients (Han and Puri, 2018) and overexpression of LSM2-(8) is associated with poor prognosis in cutaneous melanoma skin cancer (Liu et al., 2023); outcomes consistent with expression profiles observed in the TCGA-MESO cohort.